Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous technique, conolidine modulates alternate molecular targets. A Science Innovations research found that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://peterw196qst7.bligblogging.com/profile